Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile

Primary plasma cell leukemia (pPCL) is an aggressive subtype of multiple myeloma, which is distinguished from newly diagnosed multiple myeloma (NDMM) on the basis of the presence of ≥ 20% circulating tumor cells (CTCs). A molecular marker for pPCL is currently lacking, which could help identify NDMM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofste op Bruinink, Davine, Kuiper, Rowan, van Duin, Mark, Cupedo, Tom, van der Velden, Vincent H.J., Hoogenboezem, Remco, van der Holt, Bronno, Beverloo, H. Berna, Valent, Erik T., Vermeulen, Michael, Gay, Francesca, Broijl, Annemiek, Avet-Loiseau, Hervé, Munshi, Nikhil C., Musto, Pellegrino, Moreau, Philippe, Zweegman, Sonja, van de Donk, Niels W.C.J., Sonneveld, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509081/
https://www.ncbi.nlm.nih.gov/pubmed/35357885
http://dx.doi.org/10.1200/JCO.21.01217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509081/
https://www.ncbi.nlm.nih.gov/pubmed/35357885
http://dx.doi.org/10.1200/JCO.21.01217

Ejemplares similares